Image

A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or Pancreas

Exploring BI 765049 doses for advanced colon, rectum, stomach, or pancreas cancer.

Recruiting
18 years and older
All
Phase 1
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study is for adults with advanced cancer in the colon, rectum, stomach, or pancreas. Advanced cancer means the cancer can't be removed by surgery or has spread to other parts of the body. This study helps find the best dose of a new medicine called BI 765049, which might help the immune system fight cancer. People in the study will get this medicine at least every 3 weeks, for up to 3 years, as long as it is helping them.

Participants will visit the hospital regularly, sometimes staying overnight. Doctors will check their health and look out for any unwanted effects, which are health issues thought to be caused by the medicine. To learn more about the right dose, researchers will track severe health problems that happen within a week after the first dose.

  • Participants must be 18 or older and have specific cancers.
  • They must not have had major surgery within the past 28 days.
  • Regular hospital visits and potential overnight stays are required.
Print
Study details
    Colorectal Carcinoma
    Gastric Carcinoma
    Pancreatic Ductal Adenocarcinoma

NCT06882746

Boehringer Ingelheim

28 June 2025

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Race
Ethnicity
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.